These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7128666)

  • 1. Disposition of the antiepileptic oxcarbazepine and its metabolites in healthy volunteers.
    Theisohn M; Heimann G
    Eur J Clin Pharmacol; 1982; 22(6):545-51. PubMed ID: 7128666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of 10-OH-carbazepine, the main metabolite of the antiepileptic oxcarbazepine, from serum and saliva concentrations.
    Kristensen O; Klitgaard NA; Jönsson B; Sindrup S
    Acta Neurol Scand; 1983 Sep; 68(3):145-50. PubMed ID: 6650125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of food on the disposition of the antiepileptic oxcarbazepine and its major metabolites in healthy volunteers.
    Degen PH; Flesch G; Cardot JM; Czendlik C; Dieterle W
    Biopharm Drug Dispos; 1994 Aug; 15(6):519-26. PubMed ID: 7993989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacokinetics of oxcarbazepine.
    May TW; Korn-Merker E; Rambeck B
    Clin Pharmacokinet; 2003; 42(12):1023-42. PubMed ID: 12959634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gas chromatographic/mass spectrometric assays for oxcarbazepine and its main metabolites, 10-hydroxy-carbazepine and carbazepine-10,11-trans-diol.
    von Unruh GE; Paar WD
    Biomed Environ Mass Spectrom; 1986 Dec; 13(12):651-6. PubMed ID: 2952188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of renal impairment on the pharmacokinetics of oxcarbazepine and its metabolites.
    Rouan MC; Lecaillon JB; Godbillon J; Menard F; Darragon T; Meyer P; Kourilsky O; Hillion D; Aldigier JC; Jungers P
    Eur J Clin Pharmacol; 1994; 47(2):161-7. PubMed ID: 7859804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of plasma and saliva concentrations of the active monohydroxy metabolite of oxcarbazepine in patients at steady state.
    Cardot JM; Degen P; Flesch G; Menge P; Dieterle W
    Biopharm Drug Dispos; 1995 Oct; 16(7):603-14. PubMed ID: 8785383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-reactivity assessment of oxcarbazepine and its metabolites in the EMIT assay of carbamazepine plasma levels.
    Kumps A; Mardens Y
    Ther Drug Monit; 1986; 8(1):95-7. PubMed ID: 3515642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enantioselective pharmacokinetics of 10-hydroxycarbazepine after oral administration of oxcarbazepine to healthy Chinese subjects.
    Volosov A; Xiaodong S; Perucca E; Yagen B; Sintov A; Bialer M
    Clin Pharmacol Ther; 1999 Dec; 66(6):547-53. PubMed ID: 10613609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The metabolism of 14C-oxcarbazepine in man.
    Schütz H; Feldmann KF; Faigle JW; Kriemler HP; Winkler T
    Xenobiotica; 1986 Aug; 16(8):769-78. PubMed ID: 3765657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxcarbazepine disposition: preliminary observations in patients.
    Kumps A; Wurth C
    Biopharm Drug Dispos; 1990; 11(4):365-70. PubMed ID: 2340349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbamazepine metabolism in man. Induction and pharmacogenetic aspects.
    Eichelbaum M; Tomson T; Tybring G; Bertilsson L
    Clin Pharmacokinet; 1985; 10(1):80-90. PubMed ID: 3971637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of felbamate on the pharmacokinetics of the monohydroxy and dihydroxy metabolites of oxcarbazepine.
    Hulsman JA; Rentmeester TW; Banfield CR; Reidenberg P; Colucci RD; Meehan JW; Radwanski E; Mojaverian P; Lin CC; Nezamis J
    Clin Pharmacol Ther; 1995 Oct; 58(4):383-9. PubMed ID: 7586929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interference by carbamazepine and oxcarbazepine with serum- and urine-screening assays for tricyclic antidepressants.
    Saidinejad M; Law T; Ewald MB
    Pediatrics; 2007 Sep; 120(3):e504-9. PubMed ID: 17766494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of oxcarbazepine and carbamazepine in human placenta.
    Pienimäki P; Lampela E; Hakkola J; Arvela P; Raunio H; Vähäkangas K
    Epilepsia; 1997 Mar; 38(3):309-16. PubMed ID: 9070593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presence and fate of carbamazepine, oxcarbazepine, and seven of their metabolites at wastewater treatment plants.
    Leclercq M; Mathieu O; Gomez E; Casellas C; Fenet H; Hillaire-Buys D
    Arch Environ Contam Toxicol; 2009 Apr; 56(3):408-15. PubMed ID: 18779941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacokinetics of antiepileptic drugs in paediatric patients. Part II. Phenytoin, carbamazepine, sulthiame, lamotrigine, vigabatrin, oxcarbazepine and felbamate.
    Battino D; Estienne M; Avanzini G
    Clin Pharmacokinet; 1995 Nov; 29(5):341-69. PubMed ID: 8582119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and tolerability of eslicarbazepine acetate and oxcarbazepine at steady state in healthy volunteers.
    Elger C; Bialer M; Falcão A; Vaz-da-Silva M; Nunes T; Almeida L; Soares-da-Silva P
    Epilepsia; 2013 Aug; 54(8):1453-61. PubMed ID: 23758485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First dose and steady-state pharmacokinetics of oxcarbazepine and its 10-hydroxy metabolite.
    Dickinson RG; Hooper WD; Dunstan PR; Eadie MJ
    Eur J Clin Pharmacol; 1989; 37(1):69-74. PubMed ID: 2591466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early stage autoinduction of carbamazepine metabolism in humans.
    Bernus I; Dickinson RG; Hooper WD; Eadie MJ
    Eur J Clin Pharmacol; 1994; 47(4):355-60. PubMed ID: 7875188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.